Jan Doležel
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Renal and related cancers
Papers in
-
- Prostate Cancer Diagnosis and Treatment 6
- Lung Cancer Diagnosis and Treatment 5
- Renal cell carcinoma treatment 4
- Surgery 10
- Bladder and Urothelial Cancer Treatments 8
- Urinary and Genital Oncology Studies 4
- Co-authors
- Ondřej Slabý (14 shared papers)Michal Staník (27 shared papers)Marek Svoboda (12 shared papers)Dalibor Pacík (12 shared papers)Michal Fedorko (10 shared papers)Robert Iliev (8 shared papers)Alexandr Poprach (10 shared papers)Táňa Macháčková (5 shared papers)
In The Last Decade
Jan Doležel
40 papers receiving 638 citations
Peers
Comparison fields: 5 of 57
- Cancer Research 310
- Molecular Biology 363
- Pulmonary and Respiratory Medicine 140
- Urology 12
- Surgery 81
Countries citing papers authored by Jan Doležel
This map shows the geographic impact of Jan Doležel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Doležel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Doležel more than expected).
Fields of papers citing papers by Jan Doležel
This network shows the impact of papers produced by Jan Doležel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Doležel. The network helps show where Jan Doležel may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Doležel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 80 | |
| 2 | 2015 | 74 | |
| 3 | 2012 | 70 | |
| 4 | 2016 | 63 | |
| 5 | 2016 | 48 | |
| 6 | 2017 | 45 | |
| 7 | 2016 | 40 | |
| 8 | 2016 | 37 | |
| 9 | 2018 | 36 | |
| 10 | 2012 | 29 | |
| 11 | 2013 | 25 | |
| 12 | 2014 | 19 | |
| 13 | 2018 | 13 | |
| 14 | 2019 | 8 | |
| 15 | Very rare angioleiomyoma of the male urethra. | 1993 | 8 |
| 16 | 2012 | 7 | |
| 17 | 2018 | 6 | |
| 18 | Robot-assisted pulmonary lobectomy. | 2008 | 6 |
| 19 | 2000 | 5 | |
| 20 | [Sacral deafferentation and neurostimulation of anterior spinal roots in the treatment of neurogenic bladder in patients with complete transverse spinal lesions--initial clinical experience]. | 2002 | 5 |
About Jan Doležel
Jan Doležel is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Cancer Research, Molecular Biology and Oncology, having authored 50 papers that have together received 657 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (8 papers), Prostate Cancer Diagnosis and Treatment (6 papers), Lung Cancer Diagnosis and Treatment (5 papers), Renal cell carcinoma treatment (4 papers), Chromosomal and Genetic Variations (4 papers), Urinary and Genital Oncology Studies (4 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (310 citations), Molecular Biology (363 citations), Pulmonary and Respiratory Medicine (140 citations), Urology (12 citations) and Surgery (81 citations). Jan Doležel has collaborated with scholars based in Czechia, Austria and Germany. Frequent co-authors include Ondřej Slabý, Michal Staník, Marek Svoboda, Dalibor Pacík, Michal Fedorko, Robert Iliev, Alexandr Poprach, Táňa Macháčková, Jaroslav Juráček and Hana Mlčochová. Their work appears in journals such as Cancer Research, Tumor Biology, Urologic Oncology Seminars and Original Investigations, Value in Health and Cancer Genomics & Proteomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.